Josh Dubofsky

Silicon Valley
  • 140 Scott Drive
  • Menlo Park, CA 94025
  • USA

Josh Dubofsky is a partner in the Silicon Valley office of Latham & Watkins and a member of the Corporate Department. He joined Latham in 2001 and has practiced in the Silicon Valley and New York offices.


Mr. Dubofsky’s practice focuses primarily on:

  • Mergers and acquisitions
  • Strategic corporate transactions and strategic planning
  • Public and private financing transactions
  • General corporate representation of both publicly traded and privately held companies

Mr. Dubofsky represents corporate clients, private equity firms and venture capital firms in acquisitions, divestitures and debt and equity investments across a wide range of industries, including:

  • Life sciences
  • Internet and digital media
  • Information technology
  • Retail and Consumer Products
  • Transportation
  • Financial services

Mr. Dubofsky also represents both public and private companies in general corporate governance matters and securities offerings, and provides legal advice and strategic planning assistance to management, directors and shareholders.


Mr. Dubofsky’s public and private mergers and acquisitions practice has included representation of numerous companies, including:

  • US Airways in its US$17 billion merger with American Airlines
  • ArthroCare Corporation in its US$1.7 billion acquisition by Smith & Nephew
  • Toshiba Corporation in its acquisition of OCZ Technology Group through a 363 bankruptcy sale process
  • Conceptus, Inc. in its US$1.1 billion acquisition by Bayer AG
  • Medicis Pharmaceuticals in its acquisition by Valeant Pharmaceuticals for US$2.6 billion
  • Talon Therapeutics in its up to US$210 million acquisition by Spectrum Pharmaceuticals
  • Allos Therapeutics in its up to US$206 million acquisition by Spectrum Pharmaceuticals
  • Eddie Bauer in its 363 bankruptcy process sale to Golden Gate Capital for US$286 million
  • ZymoGenetics in its US$885 million acquisition by Bristol-Meyers Squibb
  • A special committee of the board of directors of Genentech in the US$47 billion acquisition of the outstanding publicly held stock of Genentech by Roche
  • Adobe Systems in its US$1.8 billion acquisition of Omniture
  • Guitar Center in its sale to Bain Capital for US$1.9 billion
  • Plexxikon in its up to US$935 million acquisition by Daichi Sankyo
  • Narus in its acquisition by The Boeing Company

Mr. Dubofsky also regularly represents private equity and venture capital firms in connection with private and public investments, acquisitions and divestitures. Representative clients have included Technology Crossover Ventures, The Carlyle Group, KKR and Weston Presidio, and recent matters include the representation of Indigo Partners in its acquisition of Frontier Airlines from Republic Airways and of Technology Crossover Ventures in public and private investments and divestitures of portfolio companies, including investments in, Netflix and MarketAxess and the sales of ExactTarget and FX Alliance.